NCT05679765|CompletedPhase 4
Efficacy of GONB in Patients of Migraine
Analgesic Efficacy of Ultrasound-guided Greater Occipital Nerve Block in Patients of Chronic Migraine
Loading search results
Analgesic Efficacy of Ultrasound-guided Greater Occipital Nerve Block in Patients of Chronic Migraine
Sponsor study identifier
interventional
50
1 country
1
Study Start
April 1, 2022
Actual (reported)Primary Completion
August 31, 2022
Actual (reported)Study Completion
August 31, 2022
Actual (reported)The study was carried to determine the analgesic efficacy of greater occipital nerve block in patients of migraine. It was a randomised controlled which took place from april 2022 - october 2022. Fifty patients suffering from migraine were included in the study. Patients in Group G were given greater occipital nerve block (GONB) with lignocaine and dexamethasone under ultrasound guidance while those in Group S were given saline 0.9% as placebo. Pain score using Numeric Rating Scale and number of headache days was assessed at four,eight and twelve weeks after the procedure as a primary outcome. Total headache days were recorded as a secondary outcome.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 31, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 1, 2022
Actual (reported)August 31, 2022
Actual (reported)August 31, 2022
Actual (reported)December 7, 2022
Actual (reported)January 11, 2023
Actual (reported)Analgesic efficacy
Change in Pain score assessed on Numeric Rating Scale (NRS) which ranges from 0 to 10. 0 is no pain and 10 is maximum pain.
12 weeks
Headache days
12 weeks
Greater occipital nerve block (GONB) under ultrasound guidance with lidocaine and dexamethasone on the side of headache
Greater occipital nerve block (GONB) under ultrasound guidance on the side of headache with 0.9% Saline (Placebo)
Ultrasound guided Greater occipital nerve block on the side of headache
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
Greater Occipital Nerve Block with dexamethasone and lidocaine
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordPain Medicine Department
Lahore, Pakistan
Moazzam Ali
Pain Medicine Department
50 participants (actual enrollment reported by the registry).
First Submitted
December 7, 2022
First Posted
January 11, 2023
Study Start
April 1, 2022
Actual (reported)Ultrasound guided Greater occipital nerve block on the side of headache
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
August 31, 2022
Actual (reported)Study Completion
August 31, 2022
Actual (reported)Last Updated
January 12, 2023
Record last verified: 2023-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: